MORGAN STANLEY - ENVVENO MEDICAL CORPORATION ownership

ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 23 filers reported holding ENVVENO MEDICAL CORPORATION in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ENVVENO MEDICAL CORPORATION
ValueSharesWeighting
Q3 2023$233,462
+104.9%
43,314
+17.1%
0.00%
Q2 2023$113,917
-15.8%
36,986
+28.0%
0.00%
Q1 2023$135,271
-12.8%
28,904
-5.0%
0.00%
Q4 2022$155,193
-23.6%
30,430
-5.7%
0.00%
Q3 2022$203,000
+89.7%
32,285
+14.2%
0.00%
Q2 2022$107,000
-53.5%
28,280
-21.3%
0.00%
Q1 2022$230,000
-38.5%
35,954
-36.6%
0.00%
Q4 2021$374,00056,7300.00%
Other shareholders
ENVVENO MEDICAL CORPORATION shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 401,200$1,517,0002.12%
KINGDON CAPITAL MANAGEMENT, L.L.C. 219,180$829,0000.14%
Perceptive Advisors 781,615$2,954,0000.09%
ARTHUR M. COHEN & ASSOCIATES, LLC 24,000$91,0000.02%
UBS OCONNOR LLC 118,113$446,000,0000.01%
Sepio Capital, LP 10,800$41,0000.00%
WELLS FARGO & COMPANY/MN 2,049$8,0000.00%
NORTHERN TRUST CORP 13,906$53,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 81,723$308,0000.00%
View complete list of ENVVENO MEDICAL CORPORATION shareholders